Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

来自 NCBI

阅读量:

480

摘要:

The article reports on the results of research which was conducted to determine the effect mepolizumab had on patients with prednisone dependent asthma with sputum eosinophilia and to determine if eosinophilic inflammation of the airway is associated with the risk of exacerbations of asthma. Researchers conducted a randomized, double-blind, placebo-controlled, parallel-group study of 61 subjects who had refractory eosinophilic asthma and a history of recurrent severe exacerbations. Researchers found that mepolizumab was associated with significantly fewer severe exacerbations than placebo over the course of 50 weeks, that there were no significant differences between the groups with respect to symptoms, FEV1 after bronchodilator use, or airway hyperresponsiveness, and that mepolizumab therapy reduces exacerbations and improves AQLQ scores in patients with refractory eosinophilic asthma. They concluded that eosinophils had a role as important effector cells in the pathogenesis of severe exacerbations of asthma in the patient population that they studied.

展开

DOI:

10.1056/NEJMoa0805435

被引量:

3313

年份:

2009

相似文献

参考文献

引证文献

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

关于我们

百度学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们保持学习的态度,不忘初心,砥砺前行。
了解更多>>

友情链接

百度云百度翻译

联系我们

合作与服务

期刊合作 图书馆合作 下载产品手册

©2025 Baidu 百度学术声明 使用百度前必读

引用